We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Influence of Cessation of Pomegranate Juice Intake on Inflammation and Oxidative Stress Markers and Glucose Control in Diabetic and Non Diabetic Chronic Hemodialysis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01033435
Recruitment Status : Completed
First Posted : December 16, 2009
Last Update Posted : August 17, 2011
Sponsor:
Information provided by:

Study Description
Brief Summary:

The current study will investigate chronic hemodialysis patients who were treated in our unit with pomegranate juice intake for 1 year - compared to a control group.

Markers will be taken 3 months after cessation of pomegranate juice intake, for inflammation and oxidative stress and Hb A1c.


Condition or disease Intervention/treatment
Inflammation Oxidative Stress Other: No intervention

Study Design

Study Type : Observational
Actual Enrollment : 49 participants
Observational Model: Case Control
Time Perspective: Prospective
Study Start Date : December 2009
Study Completion Date : August 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dialysis
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
chronic Hemodialysis patients, treated in our unit. Other: No intervention
chronic Hemodialysis patients , No intervention
chronic Hemodialysis patients, treated in our unit.


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
chronic Hemodialysis patients, treated in our unit.
Criteria

Inclusion Criteria:

  • Chronic Hemodialysis patients three months after termination of study which is currently carried out at our unit; which compared patients taking pomegranate juice three times a week for 1 year to a group that received placebo juice.

Exclusion Criteria:

  • Patients who do not currently participate in above mentioned trial
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01033435


Locations
Israel
Western Galilee Hospital
Nahariya, Western Galilee, Israel, 25100
Sponsors and Collaborators
Western Galilee Hospital-Nahariya
More Information

Responsible Party: Dr. Ronit Geron, Deputy Head of Department, Nephrology and Hypertension Department, Western Galilee Hospital, Nahariya
ClinicalTrials.gov Identifier: NCT01033435     History of Changes
Other Study ID Numbers: Gron09
First Posted: December 16, 2009    Key Record Dates
Last Update Posted: August 17, 2011
Last Verified: August 2011

Keywords provided by Western Galilee Hospital-Nahariya:
Inflammation
Oxidative stress
HbA1c
Hemodialysis

Additional relevant MeSH terms:
Inflammation
Pathologic Processes